G-CSF
Showing 26 - 50 of 6,716
The Optimization of Haploidentical Hematopoietic Stem Cell
Not yet recruiting
- Hematological Malignancy
- ATG
- Post-transplantation cyclophosphamide
-
Beijing, Beijing, ChinaPeople's Hospital of Peking University
Nov 28, 2022
Acute Myeloid Leukemia Trial in Shenyang (rhTPO)
Recruiting
- Acute Myeloid Leukemia
-
Shenyang, Liaoning, ChinaShengJing Hospital of China Medical University
Feb 17, 2022
Granulocyte Colony-Stimulating Factor, PD-1 Inhibitor Trial in Guangzhou (PEG-rhG-CSF)
Recruiting
- Granulocyte Colony-Stimulating Factor
- PD-1 Inhibitor
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Feb 2, 2022
Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Atlanta (G-CSF mobilized CD34+ selected
No longer available
- Chronic Myeloid Leukemia
- +2 more
- G-CSF mobilized CD34+ selected cells for transplantation
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Feb 28, 2022
Multiple Myeloma Trial in Worldwide (BL-8040 1.25mg/kg + G-CSF, Placebo +G-CSF)
Active, not recruiting
- Multiple Myeloma
- BL-8040 1.25mg/kg + G-CSF
- Placebo +G-CSF
-
Los Angeles, California
- +17 more
Jun 14, 2022
Follicular and Blood G-CSF During a Natural Cycle of IVF
Suspended
- Infertility
- Blood test
-
Montréal, Quebec, CanadaOvo Fertilité
Jan 7, 2022
Frailty Trial in Boynton Beach (GMFFP)
Enrolling by invitation
- Frailty
-
Boynton Beach, FloridaSouth Florida Bone Marrow/Stem Cell Transplant Institute DBA Mah
May 5, 2022
Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)
Not yet recruiting
- Lymphoma
- Peripheral Blood Stem Cell Transplantation
- Eltrombopag olamine
- (no location specified)
Jul 25, 2023
Multiple Myeloma Trial in Berne (Vinorelbine, Gemcitabine, G-CSF)
Recruiting
- Multiple Myeloma
- Vinorelbine
- +2 more
-
Berne, SwitzerlandDepartment for Medical Oncology University Hospital/Inselspital
Jul 29, 2021
Intermittent Claudication, PAD, Atherosclerotic Ischemic Disease Trial in Bangkoknoi (PB-MNC therapy, No PB-MNC therapy)
Recruiting
- Intermittent Claudication
- +2 more
- PB-MNC therapy
- No PB-MNC therapy
-
Bangkoknoi, Bangkok, ThailandFaculty of Medicine, Siriraj Hospital, Mahidol University
Dec 16, 2021
PAD, Critical Limb Ischemia, Atherosclerotic Ischemic Disease Trial in Bangkoknoi (PB-MNC therapy, No-PB-MNC therapy)
Recruiting
- PAD
- +2 more
- PB-MNC therapy
- No-PB-MNC therapy
-
Bangkoknoi, Bangkok, ThailandVascular Surgery, Siriraj Hospital, Mahidol University
Dec 16, 2021
Anterior Myocardial Infarction, Heart Failure Trial in Rome (rhu G-CSF, optimal standard of care, Myocardial Contrast
Withdrawn
- Anterior Myocardial Infarction
- Heart Failure
- rhu G-CSF
- +2 more
-
Rome, RM, ItalyFondazione Policlinico Universitario Agostino Gemelli
Mar 28, 2022
Healthy Trial run by the NHLBI (AMD 3100 (Mozobil plerixafor), Granulocyte colony-stimulating factor (G-CSF))
Completed
- Healthy
- AMD 3100 (Mozobil plerixafor)
- Granulocyte colony-stimulating factor (G-CSF)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 21, 2021
Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete
Completed
- Myeloproliferative Disorders
- +4 more
- T-cell replete PBPC allograft
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 12, 2022
Allogenic Granulocyte Donation Trial run by the National Institutes of Health Clinical Center (CC) (Filgrastim, Dexamethasone)
Recruiting
- Allogeneic Granulocyte Donation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 7, 2023
Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy)
Not yet recruiting
- Acute Myeloid Leukemia
- Myeloid Neoplasm
- Biospecimen Collection
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 5, 2023
Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen
Not yet recruiting
- Leukemia, Myeloid, Acute
- AML Stage, Adult
- Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
-
Xiamen, Fujian, ChinaBing Xu
Oct 29, 2022
Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)
Active, not recruiting
- Acute Myeloid Leukemia
- Cladribine
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 10, 2022
Pancreatic Cancer Trial in Sydney, Wollongong, Melbourne (Durvalumab, Oxaliplatin, Irinotecan)
Recruiting
- Pancreatic Cancer
- Durvalumab
- +5 more
-
Sydney, New South Wales, Australia
- +2 more
Oct 19, 2023
Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)
Not yet recruiting
- Angiosarcoma
- Paclitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 23, 2023
Healthy Volunteers Trial in Hannover (CSL324, Placebo)
Recruiting
- Healthy Volunteers
- CSL324
- Placebo
-
Hannover, GermanyFraunhofer Institute for Toxicology and Experimental Medicine
Jan 28, 2023